Medical technology company offering innovative products and services in orthopedics, medical and surgical equipment, and neurotechnology.
Profile & Fundamentals
Review the profile, reported financial history, AI financial assessment, dividends, splits, and dated events for Stryker.
Profile & Fundamentals
Stryker Profile & Fundamentals
Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.
Explore this pageJump to a Profile & Fundamentals section
Explore this research
Profile & Fundamentals contents
Jump directly to any section
Company and Market Context
Company Profile & Ownership
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Company profile record
Stryker Corporation
Common Stock · Healthcare · Medical Devices
Company
- Company / asset
- Stryker Corporation
- Security type
- Common Stock
- Sector
- Healthcare
- Industry
- Medical Devices
- HQ
- 🇺🇸 United States
- Head office
- 1941 Stryker Way, Portage, MI, United States, 49002
Leadership & scale
- Chief executive
- Mr. Kevin A. Lobo
- CEO year born
- 1965
- Full-time employees
- 56K
- Fiscal year end
- December
- IPO date
- 1988-02-01
Fundamentals snapshot
- Market Cap
- USD 125.9B
- P/E
- 37.7x
- Revenue (Q1 26)
- USD 6.0B
- Profit (Q1 26)
- USD 745.0M
- Dividend Yield
- 0.7%
- Revenue (FY 25)
- USD 25.1B
- Shares in public float
- 347.6M
- Insider ownership
- 5.37%
Reporting & identifiers
- Symbol
- SYK.NYSE
- Listing
- 🇺🇸 United States | Dividend Tax: 30%
- Ticker Currency
- USD
- Income Statement Currency
- USD
- Balance Sheet Currency
- USD
- Cash Flow Currency
- USD
- EPS Currency
- USD
- Contract Type
- SPOT
- ISIN
- US8636671013
- Asset ID
- equity_8f5a7279-ad52-55b0-8af2-9ce67e12e352
Ownership
Shares Outstanding
Latest: 386.5M | Max: 417.9M | Min: 378.4M
Complete Research Workspace
Unlock the complete Profile & Fundamentals
Sign in to verify your access, or upgrade to the Base plan to open every chart, financial statement, event, and source table.